Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

New Study from ZOE Shows Significant Inflammatory Responses After Meals

ZOE

Scientists at health science company ZOE and King’s College London today published novel research in the peer-reviewed American Journal of Clinical Nutrition. The study shows that acute and prolonged food-induced inflammation can increase the predicted risk of developing cardiometabolic diseases like cardiovascular disease. As the largest in-depth global study to look at postprandial inflammation, researchers found that inflammation, triggered by food, varies widely between individuals. Moreover, for the first time in a study of this scale, researchers were also able to identify the relative influence of blood sugar and blood fat levels on inflammation, demonstrating a stronger link with blood fat responses than blood sugar. These findings highlight the potential for personalized strategies to reduce chronic inflammation in preventative health. The facts on inflammation and food: Inflammation is a normal biological process caused by the immune system responding to injury. However, sustained long-term (chronic) inflammation is linked to many health conditions, including type 2 diabetes and heart disease Researchers measured levels of fat, sugar and inflammatory markers in the blood of 1,000 PREDICT participants who had eaten set meals at specific times, making this by far the largest study of the impact of food on postprandial inflammation in the world Most people experienced some level of inflammation after eating but the amount varied widely between people, depending on their unique biology. For the first time, this study shows that changes in the levels of fat in the bloodstream after eating have a greater influence on inflammation than blood sugar levels. This shows that only concentrating on a single measure like blood sugar or blood fat is not the right strategy for overall dietary advice There are several strategies that people can use to reduce food-induced inflammation Understanding your personal nutritional responses after eating can enable you to make food choices that will help reduce inflammation and better support your health Measuring inflammation after eating Led by Dr. Sarah Berry and her team at King’s College London and ZOE, in collaboration with Massachusetts General Hospital and additional researchers in the US, UK, Italy, Spain and Sweden, the PREDICT study invited 1,002 healthy adults taking part in the PREDICT research program to come into the team’s research clinic for a day. They were all given two standardized meals to eat, each containing precise amounts of fat, carbohydrate, fiber and protein: breakfast (a muffin and a milkshake) and lunch 4 hours later (a muffin). The researchers took blood samples from the participants before the breakfast meal and at nine points throughout the day. These were then analyzed to measure the levels of blood fat and sugar at the different timepoints, along with levels of two markers of inflammation, interleukin 6 (IL-6) and Glycoprotein acetylation (GlycA). While IL-6 has conventionally been used as a measure of inflammation, GlycA has recently emerged as a more robust marker. Higher levels of GlycA are also associated with a number of health conditions, including fatty liver, type 2 diabetes, heart disease and some cancers. Dr Sarah Berry from King’s College London, who led the study, explains, “Several small studies have previously tried to look at the relationship between food and inflammation, but the results have been inconsistent due in part to the challenges in measuring levels of inflammation after eating from blood samples. Thanks to recent advances in metabolic science, we were able to take advantage of a novel marker, GlycA, to gain new detailed insights into the connection between food and inflammation.” Additionally, the researchers also gathered detailed data on the participants’ health, including information about their typical diet, a stool sample for microbiome analysis, and a body fat scan. Individual inflammation responses after eating vary widely The researchers found that the levels of inflammation after eating varied widely between participants, including identical twins, even though everyone had exactly the same meals at the same intervals. For the first time in a study of this scale, the researchers were able to separate out the influence of blood sugar and blood fat levels on inflammation. While both unhealthy fat and sugar responses were associated with higher levels of inflammation after eating, blood fat was a stronger predictor of food-induced inflammation than blood sugar. People with more body fat and greater body mass index (BMI) were more likely to have higher levels of inflammation after eating, supporting current evidence that management of obesity will reduce chronic inflammatory burden. Levels of inflammation also tended to be higher in males than females, and in older participants than younger ones. How to control food-related inflammation Berry explains, “Experiencing inflammation after eating is a normal biological response, but prolonged, sustained periods of inflammation have been linked to health conditions such as type 2 diabetes and heart disease. If you have less healthy responses to fat or sugar, then it’s easier to overload your system after eating, leading to increased inflammation.” Based on these findings, Dr Berry recommends several strategies to help reduce the impact of inflammation after eating: Control unhealthy blood fat responses by choosing whole foods that are higher in fiber and lean protein, increasing your intake of healthy omega-3 fats from sources like fish, nuts and seeds, and reducing your overall body fat Control unhealthy blood sugar responses by choosing foods containing complex carbohydrates and fiber, such as whole grains, fruit and vegetables, and limiting sugary processed foods and sodas Reduce inflammation after eating by choosing foods that are high in ‘anti-inflammatory’ bioactive molecules such as polyphenols, found in colorful fruits and vegetables and other plant-based foods Understand your biology and choose foods that are less likely to cause unhealthy blood fat or sugar responses after eating Tim Spector, Professor of Genetic Epidemiology at King’s College London and scientific co-founder of ZOE, adds, “Previous results from our PREDICT study showed that the combination of microbes living in our guts, known as the gut microbiome, is closely linked to how we respond to food, particularly fat. We have also found that microbiome composition is strongly associated with GlycA levels, opening the door to reducing food-related inflammation and improving health by manipulating the microbiome.” To help bring this cutting-edge science to everyone, ZOE now offers an at-home test that measures blood fat, sugar and inflammation levels after eating, along with in-depth microbiome analysis, and provides personalized advice on the best foods to eat to support overall health. Professor Spector concludes, “Our PREDICT research program is the largest study of its kind in the world, and results like this mark important steps forward in unpacking the complex connection between diet, inflammation and health. Our mission at ZOE is to enable anyone to understand their own unique biology and make food choices that optimize their health through the latest advances in nutritional science.” Find out more about the ZOE at-home test and nutrition program at joinzoe.com. Notes and resources: Link to proof Read more about the PREDICT research program: joinzoe.com/post/what-is-predict Read more about how ZOE’s research uses standardized muffins to measure metabolic responses: joinzoe.com/post/muffin-metabolism-predict Read ZOE’s White Paper on inflammation, diet and health: joinzoe.com/whitepapers/dietary-inflammation Learn more about the science behind ZOE: joinzoe.com/whitepapers/overview ZOE’s previous research on the link between the gut microbiome and responses to food: joinzoe.com/post/nature-microbiome-discoveries Find out more about the ZOE at-home test and nutrition program at joinzoe.com ZOE is a healthcare science company helping people understand their body’s responses to food. By using machine learning combined with large scale human studies, ZOE is decoding the impact of nutrition on health. ZOE leads the PREDICT Studies and the COVID Symptom Study, which are the world’s largest community-powered research programs of their kind in nutrition and COVID-19 respectively. Located in London and Boston, ZOE was founded by Professor Tim Spector of King’s College London, data science leader Jonathan Wolf and entrepreneur George Hadjigeorgiou. ZOE was named one of the Deloitte Fast 50 Rising Stars in 2019 for the company’s contribution to science enabled by technology and machine learning. For more information on ZOE’s mission and science, visit joinzoe.com. Contact Details ZOE Fiana Tulip +1 817-691-3031 fiana@joinzoe.com Company Website https://www.joinzoe.com

June 08, 2021 08:34 AM Eastern Daylight Time

Image

Haystack Analytics attracts investment, powering tech teams globally and addresses developer burnout

Stockwood Strategy

Engineering insights tool Haystack Analytics, backed by Y Combinator, today announced it has secured a US$1.2m funding round which included participation from Founders Club, Y Combinator, Soma Capital, Entrepreneur First and investors Dan Siroker and Blaine Vess. Founded in 2020 by Julian Colina and Kan Yilmaz, Haystack helps build elite developer teams by providing engineering metrics and alerts proven to drive performance. Haystack improves developer productivity and software quality. Through their integration with GitHub, Haystack is able to provide live data insights that illustrate the entire delivery process from commit to deploy, being able to highlight bottlenecks like code review and team productivity. Using this feedback loop, Haystack users have increased production deployments by 58% and achieved 70% faster cycle times on average. In less than 12 months since launch, Haystack is being used by more than 7,000 developers at tech teams in GoDaddy, Microsoft, The Economist, Indiegogo and Truebill among others as revenues have increased by an average of 36% month on month. Julian Colina, CEO and co-founder of Haystack Analytics commented: “Tech teams and engineers around the world are key assets to any company and shipping software is the heartbeat and competitive advantage they seek. The efforts of developers are at the heart of processes, products and, effectively, the bottom line. Until now, it was difficult for CTOs and engineering managers to objectively know what their roadblocks are or have insights into resourcing levels. Haystack gives visibility by providing metrics and alerts to make sure nothing continues to be stuck. We are helping developers to ship faster and improve their satisfaction”. Research 1 has shown that elite performing engineering organisations are twice as likely to achieve their organisational goals and achieve a 50% higher growth rate over 3 years. It isn't just business objectives that do better, employees of elite performers are almost twice as likely to recommend their team as a great place to work. “Companies with strong technology teams are outperforming those which don't. Technology teams which follow DevOps best practice are less likely to see developers being burnt out, whilst allowing new product ideas to be experimented faster and shipping business value more reliably” added Julian Colina. The funding advances Haystack’s commitment to building intuitive one-click dashboards and alerts using GitHub data. Haystack plans to expand its offering to a greater range of data sources whilst providing an ever greater variety of user-friendly alerts and insights. As companies move to hybrid office/home working environments, Haystack provides insights that teams need to experiment with their workflows to prevent developer burnout whilst shipping faster. “Our mission is to bring the competitive advantage data-driven engineering teams like Google have to everyone. We help teams track their delivery process and optimization opportunities instead of relying solely on gut feelings - resulting in 70% faster delivery on average. It’s been an incredible 12 months and we are well set to achieve much more in the next year” concluded Julian Colina. Ends 1 DevOps Research and Assessment, State of DevOps report About Haystack Analytics Haystack was founded in 2020 by Julian Colin and Kan Yilmaz for tech teams to learn more about roadblocks to their work, improve productivity and importantly identify burnout issues with developers. Haystack helps build elite developer teams by providing engineering metrics and alerts proven to drive performance, improve developer productivity and software quality. Through their integration with GitHub, Haystack is able to provide live data insights that illustrate the entire delivery process from commit to deploy, being able to highlight bottlenecks like code review and team productivity. Using this feedback loop, Haystack users have increased production deployments by 58% and achieved 70% faster cycle times on average. Contact Details Haystack Analytics Bilal Mahmood +44 7714 007257 bilal@usehaystack.io Company Website https://www.usehaystack.io/

June 07, 2021 11:00 AM Eastern Daylight Time

Image

Global investors back fintech KTrade - the ‘Robinhood’ of Pakistan

Stockwood Strategy

Leading Pakistani fintech stock trading app KTrade today announced it has raised $4.5m in a funding round from a range of global investors and institutions led by Hong Kong-based TTB Partners, and HOF Capital from New York. German fintech investor Christian Angermayer, the Managing Partner of German bank Berenberg David Mortlock, and leading Pakistani business families also participated in the round. KTrade is the fintech retail trading app created by KASB Securities, the leading stock brokerage in Pakistan. KTrade provides easy access to financial markets for retail investors much like its global peers such as XP in Brazil, Zerodha and Groww in India, Tiger in China, Flatex in Germany and Robinhood in the US. Since launching in 2019, KTrade has over 200,000 users and aims to reach 10 million Pakistani’s at home and abroad by 2023 to invest in stocks, bonds, commodities and mutual funds through its mobile platform. The Karachi Stock Exchange Index (KSE100) has rallied by 19% per annum over the past 20 years despite regular market cycles. The volumes have increased by 7x over the last 18 months driven by regulatory reforms and increase in retail investor participation. Retail investors now account for over 65% of overall trading volume compared to around 45% 24 months ago. KTrade aims to provide users quick and easy accessibility to this investment opportunity. Ali Farid led the creation of KTrade. He was previously the CFO of UK listed fintech company SafeCharge (acquired by Nuvei) and a Partner at Autonomous Research (acquired by Alliance Bernstein) in London. Ali is a Rhodes Scholar and has been a top ranked Technology Analyst in Europe since 2013. Ali Farid, Co-founder of KTrade commented: “People in Pakistan have traditionally turned to gold or real estate when they consider investment options. However, as the regulatory approach, authority and credibility of the Karachi Stock Exchange has grown, more people are getting comfortable with stock market investing. This is an exciting trend but accessibility to these markets remains a hurdle for millions. KTrade will enable this mobile-first population to participate in the investment opportunity. By connecting these people to companies we can drive capital trapped in unproductive assets into the formal economy which would eventually drive a virtuous cycle of economic growth and higher investments”. Pakistan is emerging on the radar of global investors as the next Indonesia. A large, young and growing middle class and high smartphone penetration have created ideal conditions for technology led disruption. KASB’s aim is to provide retail savers access to financial education, information and financial products and to help them make better financial decisions. “Most people in Pakistan lack access to formal financial products and their savings in real estate or gold offer inferior returns, are inefficient and have high transactional costs. We aim to democratise access to the capital markets and enable them to make stock market investments. The strong demand for KTrade shows that the market is ready for this transformation. Other regional and emerging markets have seen similar evolution led by successful fintech companies” added Ali Farid. “Pakistan and South Asia have some of the most exciting market dynamics and demographics globally, and KTrade is well positioned to take advantage of the democratisation of finance in the region” said Jonathan Bond, Managing Partner TTB Partners who were lead investors in the funding round. “We are delighted to be investing in the latest round of funding for KASB, and to support Ali and his first-class team on their continued journey. We have been extremely impressed by what KASB has built over the past few years, both from a tech perspective and from the educational overlay to investing, which the company has embraced. In particular, we believe that in KTrade, the company has a stellar solution to expanding stock market participation across Pakistan” added Jonathan Bond. About KASB Securities KASB is the leading stock brokerage in Pakistan. It is a member of the Pakistan Stock Exchange and Pakistan Mercantile Exchange and regulated by the Securities and Exchange Commission of Pakistan. KASB’s mission is to democratise investments by giving people in Pakistan easy access to financial information, education and products. It operates KASB Varsity, an online MOOC, and KTrade, the leading stock trading application in Pakistan. KASB’s goal is to channel capital to financial markets by broadening the breadth of the capital markets. Further information visit: https://kasb.com or follow the company on LinkedIn, Facebook, Twitter or Instagram and through YouTube. Contact Details Stockwood Strategy Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://kasb.com/ktrade/

June 07, 2021 07:00 AM Eastern Daylight Time

Image

American Kidney Fund Commends Maryland General Assembly, Governor Hogan for Signing Living Organ Donor Protections into Law

American Kidney Fund

The American Kidney Fund (AKF) commends Maryland governor Larry Hogan for signing HB 10/SB 48, which offers additional protections for living organ donors in the state, into law. This important legislation will help living organ donors cover out-of-pocket expenses associated with their lifesaving organ donation. HB 10/SB 48 increases the amount of tax credits living organ donors can claim for unreimbursed expenses from $7,500 to $10,000, and expands the definition of qualified expenses to include childcare, eldercare and medication costs. “Governor Hogan’s signature on this bill is significant in supporting living organ donors and removing the barriers to living organ donation in Maryland,” said LaVarne A. Burton, AKF President and CEO. “We applaud the governor and the Maryland General Assembly for expanding tax credits for Marylanders, who should be encouraged to become living donors, not face hurdles that keep them from potentially saving someone’s life.” AKF worked closely with Delegate Karen Young and Senator Ron Young to move these bills through the Maryland General Assembly. AKF has a robust public policy agenda that includes making more kidney transplants possible and is leading a nationwide effort to pass living donor protections both at the state and federal level. Since 2019, 17 states have signed into law living donor legislation spearheaded by AKF. With a B grade on AKF’s 2021 State of the States: Living Donor Protection Report Card, Maryland is one of the leaders in the nation when it comes to protecting living organ donors. This bill improves upon and strengthens the state’s existing law to provide tax credits to living donors. Tax credits for living organ donors is one of the seven types of legislation states can enact to provide protections for living organ donors and encourage living donations that is measured by AKF’s Report Card. In the absence of federal legislation to protect living donors, there is an uneven patchwork of protections across the nation, with some states providing no protections at all. The overall grade average for the United States is a D. Most transplanted organs are from deceased donors, but patients may also receive organs from living donors. Living donation offers an alternative for individuals awaiting transplantation from a deceased donor and increases the existing organ supply. Transplants from living donors generally have fewer complications than deceased-donor transplants and a longer survival of the donor organ. There are more than 107,000 Americans on the organ transplant waiting list and nearly 93,000 of them, or 86%, are waiting for a kidney. Of the 23,644 kidney transplants performed in the U.S. in 2020, just 5,234 were made possible by living organ donors. In Maryland, 77 of 389 kidney transplants in 2020 were from living donors. AKF provides long-term financial assistance that makes transplants and post-transplant care possible for low-income dialysis patients. In 2020, AKF grants helped 1,615 people nationwide receive kidney transplants—7% of all kidney transplants performed in the United States last year. AKF’s program helps post-transplant patients for their full insurance plan year, ensuring continuity of care. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. 11921 Rockville Pike, Suite 300, Rockville, MD 2085 Contact Details Ben Shannon Work: +1 202-559-2813 Mobile: +19193603039 AKF@jpa.com Company Website http://www.kidneyfund.org/

June 03, 2021 05:15 PM Eastern Daylight Time

LambdaTest rallies global investors raising US$16m Series B funding as it rapidly scales

Stockwood Strategy

Cloud-based browser testing platform LambdaTest today announced it has secured US$16 million in Series B funding led by Sequoia Capital India. Telstra Ventures, MENA region investor Wamda Capital and a leading sovereign wealth fund also joined the series B round. Founded in 2017 by Asad Khan and Jay Singh, San Francisco-based LambdaTest is a cloud-based testing infrastructure company that allows users to seamlessly test their websites’ and apps’ look, feel and performance on over 2,000 different browsers and by operating systems and device combinations. The proliferation of devices and browsers has made it increasingly complex for developers to test their websites and apps. LambdaTest solves this problem by enabling developers to run a variety of tests through their cloud-based platform, spotlight concerns, share immediately with teams and remedy issues quickly. LambdaTest exists to support the developer community to identify defects in code much earlier in the release cycle. These defects present one of the biggest challenges and costs facing businesses. Indeed, the cost of fixing these defects once in production and release is 30x higher than addressing earlier in the development cycle. Since its launch, LambdaTest has attracted over 500,000 developers in 132 countries who have performed more than 20 million tests. Customers include SMEs and Fortune 500 companies such as Xerox, Cisco, Microsoft, Deloitte, Media.net, Coca Cola, Trepp, SurveyMonkey, Capgemini, HBR, 23andme and Dashlane. Asad Khan, CEO of LambdaTest commented: “Companies are increasingly competing on customer experience 1 and as such are releasing software updates faster, more frequently to remain relevant. In doing so, there is a greater demand for continuous testing to ensure quality releases in the production environment. In just six short months since the series A round in 2020, LambdaTest has doubled revenues and increased customer numbers by 20%. In that time headcount has doubled in size from 70 people pre-Series A to 150 today across the engineering, sales, and customer success teams. Harshjit Sethi, Principal at Sequoia India commented: “As every company is becoming a software company and deployment cycles are shrinking, testing is becoming an increasingly important part of the software development cycle. Additionally testing is now happening earlier and earlier in the development cycle as part of the ‘Shift Left’ movement that companies like LambdaTest are enabling. Operating in a USD 35 billion market for testing software and services, LambdaTest has emerged as the go-to platform for its users in browser testing, evident from its best-in-class ratings across review sites. Sequoia Capital India is excited to continue partnering with the LambdaTest team as they execute on their vision of building an end-to-end testing system for developers to enable companies to release more reliable software faster.” The number of software tests run by developers has almost doubled from 12m to over 20m in six months at LambdaTest. As developers shift to cloud-based testing, this number will grow exponentially. This trend has been accelerated by the adoption of the Shift Left approach, as more developers are testing code early before they ship to the testing cycles. “LambdaTest’s vision is to empower 23 million developers and testers worldwide with a powerful, comprehensive and secure continuous quality test platform. Our upcoming product lines will enable tech teams to ship high quality code seamlessly boosting their release velocity” added Asad Khan. Steve Schmidt, General Partner at Telstra Ventures commented: “We have an opportunity to build a very large scale and independent testing company with a modern approach to software development and that’s very exciting. Lambdatest has already signed several customers in Australia without having any local presence and we look forward to helping them build out a local APAC team to meet this demand”. The funding advances LambdaTest’s commitment to scaling the testing ecosystem and building next-generation cloud infrastructure for users. To this end, LambdaTest is broadening its reach with the tester community by engaging with developers as it launches a suite of products in 2021 designed for them to perform tests on scale. “We’ve had an exciting period of growth and there is more to come as we expand our platform capabilities and go deeper in global markets. This funding round validates our efforts in building a robust cloud testing platform that is truly resonating with the testing and developer community globally. We pride ourselves in delivering a highly reliable, stable and secure infrastructure for them to achieve success. This success is born out in the numbers as our customers have been able to increase release velocity by over 60% and half the time to market” concluded Asad Khan. About LambdaTest LambdaTest is a cloud testing infrastructure company that allows users to run both manual and automated tests on their websites and webapps across 2000+ different browsers, browser versions and operating system environments. The platform has been used to perform over 20 million tests in just three years, and is now being used by over 500,000 users across 132 different countries. Contact Details LambdaTest Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

June 02, 2021 05:00 AM Eastern Daylight Time

Image

American Kidney Fund Receives Support from Bayer to Expand Kidney Disease Education Among U.S. Veterans

American Kidney Fund

The American Kidney Fund (AKF) today announced support from Bayer for AKF’s effort to educate military veterans about the central role their kidneys play in their overall health and the importance of early detection to prevent or slow the progression of kidney disease. Bayer’s collaboration supports AKF’s existing partnership with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to increase awareness of kidney disease among U.S. veterans and to support veterans who have been diagnosed with kidney disease. “About 500,000 U.S. veterans have kidney disease, and that number continues to trend upward by 6% each year, as it has for the past five years,” said LaVarne A. Burton, AKF president and CEO. “We are grateful for Bayer’s support of our work to reach out to veterans—a population that faces higher rates of kidney disease compared to the general public.” "A major risk factor for chronic kidney disease is type 2 diabetes and many veterans living with type 2 diabetes do not realize they are at risk," said Amit Sharma, M.D., FACP, FASN, FNKF, Vice President of Medical Affairs, Cardiovascular & Renal Division, Bayer. “Bayer is proud to support AKF’s work to educate America’s veterans on kidney disease risk factors, early detection and disease management, to help all veterans living with kidney disease live healthier lives.” Kidney disease is the fastest growing noncommunicable disease in the U.S., yet 90% of Americans, including veterans, with the early stages of kidney disease are unaware they have it because there are typically no symptoms until the later stages. Diabetes and hypertension cause 75% of all new cases of kidney disease. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. 11921 Rockville Pike, Suite 300, Rockville, MD 20852 Contact Details Ben Shannon Work: +1 202-559-2813 Mobile: +19193603039 AKF@jpa.com Company Website https://www.kidneyfund.org

May 27, 2021 09:00 AM Eastern Daylight Time

British online store The Edit LDN transforms prized sneaker industry as sales soar

Stockwood Strategy

The UK’s leading online store for limited edition sneakers and high end streetwear The Edit Man London has become The Edit LDN. The name change reflects the rapidly growing female appeal for new and pre-loved sneakers and streetwear as sales grow 60% month-on-month in the last 12 months. The Edit LDN is an online consignment store that sells new and pre-loved goods from a variety of brands including Yeezy, Jordan, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others to a wide community of fashionistas, collectors and investors. Just as premium sites like Farfetch address the fashion world, The Edit LDN is the leading destination for limited edition sneakers and high end streetwear. They connect premium resellers with a highly engaged, price agnostic and eager audience. Through partnerships with styling services such as Thread.com and various concierge companies, THE EDIT LDN has expanded its community of buyers from TV and film celebrities to professional footballers and royal families around the world. Moses Rashid, founder and CEO of The Edit LDN commented: “As a brand we want to remain current and relevant to our community, our new name now fairly represents and embraces our diverse community but is true to its origins. We dropped the ‘Man’ from the name simply because the number of women buying had been steadily increasing since launch in January 2020 and passed 50% in March this year. It was the right thing to do.” The Edit LDN has established itself as a trusted source of authenticated and high quality new and pre-loved streetwear and sneakers. Their unabating focus on speed (to deliver purchased goods), customer service engagement and ensuring all goods are authenticated has been testament to the growth of the platform and community. “We set out to create a destination that opens up and levels up the opportunity for anyone wishing to own extremely limited edition goods. Essentially we make Inaccessible, accessible. Previous means to buy these goods have been riddled with issues such as sending payments to random resellers found on social media, authenticity issues when buying online and long delivery times on purchases from global marketplaces. The Edit LDN addresses all these concerns and is transforming the customer experience and industry simultaneously, added Moses ”. In 2021 (to April), The Edit LDN attracted more traffic, transactions and revenue than in their first year of trading (2020). With 60% month-on-month growth and mounting interest, the business is set to take-off. “We’re regularly selling sneakers and streetwear worth £1,500 each. Recently, we sold a Gucci TNF jacket for £9,200. It’s not only the variety of goods we offer but the speed at which we send purchases. Just last year we managed to source and sell 44 Playstation 5 games consoles to the England U21 football team within 24 hours, literally dispatching them in Ubers to their homes” said Moses. Looking ahead, Moses added: “This is a marketplace worth $6b a year globally and will grow 5x by 2030. By the end of this year, The Edit LDN will be worth £10m and given the hyper growth rate of our sales and revenues, we will 3x our valuation by the end of 2022 for sure. In meeting the needs of this rapid scaling, we will seek to raise funds this year to propel us as we launch in new markets”. The Edit LDN has its community and social conscious front of mind. They have raised funds and awareness against gun crime, mental health and sustainability issues. In 2020, the company collaborated with the artist McCrow as part of the One Less Gun campaign to create a sneaker with bullet shells from an AK-47 rifle. Working with Gary James McQueen in aid of MIND mental health charity, they raised funds with an exclusive T-shirt drop featuring the famous McQueen Vanitas skull. In owning their sustainability agenda, they turned their focus to the circular economy by selling pre-owned (or pre-loved) goods through the platform. In addition to this, they are a paperless company and only ship products using recycled packaging. “At the heart of The Edit LDN proposition is a focus on social and economic issues. These are matters that are important to us and our community, so we recognise that we’re in a super hot market right now so we want to use our platform to make a long lasting impact where possible” concluded Moses. About The Edit LDN Founded in 2020, The Edit LDN has quickly become the UK’s leading online consignment store for limited edition sneakers and high end streetwear, both new and pre-loved items. Their innovative platform connects premium resellers to a global audience offering a deluxe experience from discovery, packaging and delivery. Brands include Jordan, Yeezy, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others. The platform is fast becoming synonymous with speed of service, authenticity, diverse selection of secure payment methods, and first class customer service. The Edit LDN is the leading destination for resellers and their premium sneakers and streetwear. Through partnerships with styling services such as Thread.com and various concierge companies, The Edit LDN has a community of buyers celebrities to professional footballers and royal families around the world. Contact Details The Edit LDN Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

May 27, 2021 05:00 AM Eastern Daylight Time

Image

Elsevier Supports the State of California in Expanding COVID-19 Online Learning Program for Registered Nurses

Elsevier

In response to the increased need for skilled healthcare workers during the pandemic, many hospitals in California are calling upon adjunct nursing staff that don’t typically work in the ICU to offer additional support in the care of critically ill patients Elsevier, a global leader in research publishing and information analytics, announced today that it is working with the State of California Emergency Medical Services (EMS) Authority and the American Association of Critical-Care Nurses (AACN) to expand its COVID-19 online training for adjunct nursing staff who can provide additional support in the intensive care units (ICU) during the pandemic. The week-long online curriculum, created by the AACN, is designed to help adjunct nursing staff who don’t typically work in the ICU to enhance their clinical skills and knowledge on caring for patients with the novel coronavirus, SARS-CoV-2. Registered nurses in California can learn more about this continuing education training option and how to register by visiting the EMS Authority’s website. John Danaher, MD, President, Clinical Solutions, Elsevier, said: “We are continuing to work with the State of California to support frontline workers who are playing such an important role in our local communities. Hundreds of newly trained nurses in California have completed the initial training program and are providing additional support in ICUs across the state. We look forward to our continued collaboration and doing everything we can to support patient care.” Some of the learning modules included in the expanded program include Critical Care Patient Management, Acute Coronary Syndrome (ACS), Assessing and Managing Respiratory Failure, and Managing Oxygenation and Ventilation. Elsevier is committed to supporting clinicians and students and helping them improve outcomes. In April 2020, Elsevier launched its COVID-19 Healthcare Hub, which provides free access to toolkits, expert insights, research resources and COVID-19 guidelines. The Hub’s resources include evidence-based clinical overviews, drug monographs, care plans, order sets, and procedure videos for clinicians delivering care and information to patients. Clinicians will also find the latest information and guidelines from government health agencies, medical societies and public health organizations for diagnosis, testing and treatment of COVID-19 patients. To help address the wave of misinformation about the virus and support clinicians in India, Elsevier recently launched the India Covid-19 Healthcare Hub. The website includes short synoptic clinical overviews, medication information, and easy-to-understand videos and instructions for patients. Additionally, AACN hosts a COVID-19 Resources page on its association site that provides free access to clinical and supportive resources ensuring nurses have the information and support to best care for their patients and themselves throughout the pandemic. About the American Association of Critical-Care Nurses For more than 50 years, the American Association of Critical-Care Nurses (AACN) has been dedicated to acute and critical care nursing excellence. The organization’s vision is to create a healthcare system driven by the needs of patients and their families in which acute and critical care nurses make their optimal contribution. AACN is the world’s largest specialty nursing organization, with more than 130,000 members and over 200 chapters in the United States. American Association of Critical-Care Nurses, 27071 Aliso Creek Road, Aliso Viejo, CA 92656; 949-362-2000; www.aacn.org; facebook.com/aacnface; twitter.com/aacnme About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details American Association of Critical-Care Nurses – Communications Kristie Aylett kristie.aylett@aacn.org Elsevier Communications – Vice President, Global Health Markets Teresa Mueller +31620987384 t.mueller@elsevier.com

May 26, 2021 01:45 PM Pacific Daylight Time

Is it Possible to Kill Corona Virus from Luggage Surfaces in Just 5 Seconds? University Study Says "Yes"

WarpUV

Following extensive testing, the Microbial Pathogenesis Laboratory at Tel Aviv University has concluded the WarpUV ® AirFort® luggage disinfection system can eradicate coronaviruses in just five seconds. For airports, baggage handlers and air passengers, the study findings show air travel can be safer again because luggage surface areas that typically pass through many hands on their way to, from and at the airport, and susceptible to airborne transmissible droplets, can be safely and quickly sanitized. Prof. Anat Herskovits, a world-renowned microbiologist, Vice Chair of the Shmunis School of Biomedicine and Cancer Research, and President of the Israel Society of Microbiology, tested the ability of the WarpUV AirFort® technology to kill high concentrations of coronaviruses. “Our results concluded that after five seconds of UV irradiation, more than 99 percent of the viruses were eradicated,” Prof. Herskovits said. “I feel confident that WarpUV has developed an effective solution for luggage disinfection.” Resources: Hear audio quote from Prof. Herskovits (.wav,.mp3) Post-COVID-19 Air Travel/Bio-Security survey, May 2021 Breakthrough Rapid-Action Coronavirus and Bacteria Disinfection Technology for Passenger Luggage at Airports Stops Local Outbreaks from Becoming Global Pandemics AirFort® is designed to rapidly kill viruses, bacteria, and spores from surface contamination of carry-on and checked bags, personal items and oversized bags and parcels, protecting baggage handlers, aviation staff, and the general public. It utilizes a proprietary array of ultraviolet lights designed to achieve all-angle “360° x 360°” disinfection of all baggage surfaces. While floor UV cleaners and other disinfection agents such as sprays are being implemented globally, AirFort focuses on luggage – one of the means that the International Air Transport Association (IATA), European Union Aviation Air Safety Agency (EASA), and the U.S. Department of Homeland Security identified as a possible critical path for viruses and bacteria to infect and spread. By eradicating these harmful elements before and after flights, WarpUV has an important role in stopping the spread and future spread of pandemics which are imminent threats as described by the EU, WHO, and the World Economic Forum. About WarpUV Warp Technologies and its AirFort® devices are the frontline of prevention of the spread of pandemic by luggage and baggage in airports worldwide and serve as a “disinfection firewall” for continents, countries, and regions. The company was formed in 2020 by veteran Israeli entrepreneurs Amir Fischer, Eitan Haimovich, and Gil Luxenbourg. For more information, visit www.warpUV.com. Contact Details Rainier Communications Alan Ryan +1 508-577-6635 alanryan@rainierco.com Rainier Communications Joanne Stanway +19782731473 jstanway@rainierco.com Company Website https://www.warpuv.com/

May 26, 2021 02:30 PM Eastern Daylight Time

1 ... 269 270 271 272 273 ... 303